Pri-Med Podcasts

A primary care podcast featuring expert faculty discussing the most recent developments in the medical field. Podcast formats include, but are not limited to: expert clinical discussions, frequently asked questions, and Frankly Speaking About Family Medicine with Dr. Frank Domino. Many Pri-Med Podcasts are available for CME Credit! For CME podcasts, find the link to claim credit in those episodes’ descriptions or find the episode on our Pri-Med Podcast landing page, www.pri-med.com/podcast

Listen on:

  • Apple Podcasts
  • Podbean App
  • Spotify
  • Amazon Music
  • TuneIn + Alexa
  • iHeartRadio
  • PlayerFM
  • Listen Notes
  • Podchaser
  • BoomPlay

Episodes

Monday Nov 06, 2023

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-353
Overview: Bronchiolitis caused by respiratory syncytial virus (RSV) infection in infants is common and can lead to hospitalization if severe. There are now 2 ways to prevent this: immunizing the mother during pregnancy or giving monoclonal antibodies. Listen in as we discuss the recommendations for RSV prevention and how to best incorporate them into your practice.
Episode resource links:
Fleming-Dutra KE, Jones JM, Roper LE, et al. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morb Mortal Wkly Rep 2023;72:1115–1122.
Jones JM, Fleming-Dutra KE, Prill MM, et al. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morb Mortal Wkly Rep 2023;72:920–925
Kampmann B, Madhi SA, Munjal I, et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023;388(16):1451-1464.
Guest: Alan M. Ehrlich MD, FAAFP Music Credit: Richard Onorato

Monday Oct 30, 2023

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-352
Overview: Keep your practice at the forefront of outpatient COVID-19 management with this informative episode. Listen in as expert faculty discuss the latest recommendations and review ineffective treatments, helping you provide the best care during this new phase of the endemic.
Episode resource links:
https://www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-adults/clinical-management-of-adults-summary/?utm_source=site&utm_medium=home&utm_campaign=highlights
Abdool Karim, S. S., & Devnarain, N. (2022). Time to stop using ineffective COVID-19 drugs. New England Journal of Medicine, 387(7), 654-655.
Hayden, M. K., Hanson, K. E., Englund, J. A., Lee, F., Lee, M. J., Loeb, M., ... & Mustafa, R. A. (2023). The Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: antigen testing. Clinical Infectious Diseases, ciad032.
Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato

Monday Oct 23, 2023

Credits: 0.50 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/pain-management-outcomes-special-populations 
Overview: Tapering opioids is frequently necessary in clinical practice, either to reduce harm or because of lack of significant benefit. The most important aspect of opioid tapering is discussing the reasons for it with the patient. Opioid tapering should be a measure of safety—and in no way punitive. Complete this activity to learn appropriate and inappropriate reasons for tapering opioid therapy and strategies to counsel patients and manage withdrawal and psychological issues.
This  activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Monday Oct 23, 2023

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-351
Overview: Live at Pri-Med East! In this episode, we will examine the association of developmental delays with amount of screen time in children.
Episode resource links:
https://jamanetwork.com/journals/jamapediatrics/fullarticle/2808593
https://www.aap.org/en/patient-care/media-and-children/center-of-excellence-on-social-media-and-youth-mental-health/social-media-and-youth-mental-health-q-and-a-portal/middle-childhood/middle-childhood-questions/screen-time-guidelines/
https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx
Guest: Jillian Joseph, MSPAS, PA-CMusic Credit: Richard Onorato

Monday Oct 16, 2023

Credits: 0.50 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/pain-management-breaking-opioid-cycle 
Overview: Tapering opioids is frequently necessary in clinical practice, either to reduce harm or because of lack of significant benefit. The most important aspect of opioid tapering is discussing the reasons for it with the patient. Opioid tapering should be a measure of safety—and in no way punitive. Complete this activity to learn appropriate and inappropriate reasons for tapering opioid therapy and strategies to counsel patients and manage withdrawal and psychological issues.
This  activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdffor a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Monday Oct 16, 2023

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-350
Overview: Nuts have a reputation for providing a variety of health benefits, but how far do their nutritional superpowers reach? In this episode, we take a look at the findings of a study showing the association between nut consumption and cognitive performance. Listen in as expert faculty discuss the implications for managing patients at risk for cognitive decline.
Episode resource links:
The American Journal of Clinical Nutrition https://doi.org/10.1016/j.ajcnut.2023.05.032
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato

Monday Oct 09, 2023

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-349
Overview: Recent observational data has shown the potential for bariatric surgery to lower breast cancer risk in women with obesity. Tune in as faculty discuss what the evidence says about this connection and when to consider exploring the option for your patients’ weight-loss management.
Episode resource links:
AMA Surg. 2023 Jun 1;158(6):634-641. doi: 10.1001/jamasurg.2023.0530.
J Natl Cancer Inst. 2003;95(16):1218.
J Natl Cancer Inst. 2015;107(2) Epub 2015 Mar 10. 
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato

Monday Oct 02, 2023

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-348
Overview: Discover how wearable fitness devices are transforming early detection of atrial fibrillation with their potential to reduce stroke risk. In this episode, we share insights on leveraging smartwatches to improve health outcomes and when to encourage their use in patient care.
Episode resource links:
Bedi, A., Al Masri, M. K., Al Hennawi, H., Qadir, S., & Ottman, P. (2023). The Integration of Artificial Intelligence Into Patient Care: A Case of Atrial Fibrillation Caught by a Smartwatch. Cureus, 15(3).
Long, K. Y., Shanmugam, K., & Rana, M. E. (2023, January). An Evaluation of Smartwatch Contribution in Improving Human Health. In 2023 17th
International Conference on Ubiquitous Information Management and Communication (IMCOM) (pp. 1-4). IEEE.
Mattison, G., Canfell, O. J., Forrester, D., Dobbins, C., Smith, D., Reid, D., & Sullivan, C. (2023). A step in the right direction: the potential role of smartwatches in supporting chronic disease prevention in health care. The Medical Journal of Australia, 218(9), 384-388.
Meza, C., Juega, J., Francisco, J., Santos, A., Duran, L., Rodriguez, M., ... & Pagola, J. (2023). Accuracy of a Smartwatch to Assess Heart Rate Monitoring and Atrial Fibrillation in Stroke Patients. Sensors, 23(10), 4632.
https://www.stroke.org/en/about-stroke/types-of-stroke/cryptogenic-stroke
 
Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato

Monday Sep 25, 2023

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-347
Overview: In this episode, we’re diving into recent research that uncovers a compelling link between obstructive sleep apnea and cognitive decline in older adults. Join expert faculty as they dissect the findings and provide invaluable insights to comprehensively address this connection in your practice.
Episode resource links:
Discuss recent evidence that links obstructive sleep apnea (OSA) to cognitive decline risk in older people
Describe ways to incorporate this new evidence to identify OSA and reduce the risk of cognitive decline 
Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato

Monday Sep 18, 2023

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-346
Overview: As we encounter more patients asking about the recent FDA approval of a new respiratory syncytial virus (RSV) vaccine for older adults, it’s crucial that we keep up to date. Join us as we review the supporting studies, indications, and precautions, giving you confidence in conversations with inquiring patients. 
Episode resource links:
https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato

Copyright 2024 All rights reserved.

Version: 20241125